(Q40277463)

19 September 2017

title

GM-CSF-surface-modified B16.F10 melanoma cell vaccine (English)

1 reference

19 September 2017

Jimin Gao

1

1 reference

19 September 2017

Shuqi Huang

2

1 reference

19 September 2017

Ming Li

3

1 reference

19 September 2017

Rongcheng Luo

4

1 reference

19 September 2017

Xiaoning Wang

5

1 reference

19 September 2017

Akira Takashima

6

1 reference

19 September 2017

language of work or name

English

0 references

publication date

4 May 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

24

1 reference

19 September 2017

issue

25

1 reference

19 September 2017

page(s)

5265-5268

1 reference

Streptavidin-containing chimeric proteins: design and production

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.031

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.031

Bi-functional cytokine fusion proteins for gene therapy and antibody-targeted treatment of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.031

Novel membrane-bound GM-CSF vaccines for the treatment of cancer: generation and evaluation of mbGM-CSF mouse B16F10 melanoma cell vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.031

Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.031

10.1016/J.VACCINE.2006.04.031

7 January 2021

Identifiers

DOI

1 reference

19 September 2017

1 reference